These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20414834)

  • 1. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC; Kaya Z; Katus HA; Andrassy M
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1: the missing link between diabetes mellitus and heart failure.
    Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
    Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.
    Dumitriu IE; Baruah P; Bianchi ME; Manfredi AA; Rovere-Querini P
    Eur J Immunol; 2005 Jul; 35(7):2184-90. PubMed ID: 15915542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dealing with death: HMGB1 as a novel target for cancer therapy.
    Lotze MT; DeMarco RA
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 (HMGB1) downregulates cardiac transient outward potassium current (Ito) through downregulation of Kv4.2 and Kv4.3 channel transcripts and proteins.
    Liu W; Deng J; Xu J; Wang H; Yuan M; Liu N; Jiang Y; Liu J
    J Mol Cell Cardiol; 2010 Sep; 49(3):438-48. PubMed ID: 20483361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
    Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
    Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high mobility group box 1 (HMGB1) in wound healing.
    Zhang Q; O'Hearn S; Kavalukas SL; Barbul A
    J Surg Res; 2012 Jul; 176(1):343-7. PubMed ID: 21872885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
    Thierry S; Gozlan J; Jaulmes A; Boniface R; Nasreddine N; Strauss F; Maréchal V
    AIDS; 2007 Jan; 21(3):283-92. PubMed ID: 17255735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod.
    Zamora R; Grishin A; Wong C; Boyle P; Wang J; Hackam D; Upperman JS; Tracey KJ; Ford HR
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G643-52. PubMed ID: 15947118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor angiogenesis by HMGB1 A box peptide.
    Zhang CL; Shu MG; Qi HW; Li LW
    Med Hypotheses; 2008; 70(2):343-5. PubMed ID: 17630223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses.
    Kim TH; Ku SK; Bae JS
    Food Chem Toxicol; 2012 Mar; 50(3-4):1118-23. PubMed ID: 22178603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.